Health

Biogen scraps Alzheimer's trial, shares skid

Health News (Reuters) - 2 hours 55 min ago
Biogen and partner Eisai Co Ltd are ending two late-stage trials testing an Alzheimer's drug, they said Thursday, marking the latest setback for an industry keen to develop treatments for the memory-robbing disease.
Categories: Health

Roche sues U.S. executives in fight over diabetes test strips

Health News (Reuters) - 3 hours 34 min ago
Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips.
Categories: Health

Biogen, Eisai scrap Alzheimer drug trials

Health News (Reuters) - 4 hours 27 min ago
Biogen Inc and Eisai Co Ltd said on Thursday they will discontinue two late-stage trials testing an experimental treatment for Alzheimer's disease.
Categories: Health

Jury finding upends Bayer's Roundup defense strategy: experts

Health News (Reuters) - 13 hours 30 min ago
Bayer AG had hoped a new trial strategy focusing jurors on scientific evidence could stem a burgeoning tide of U.S. lawsuits over its glyphosate-based weed killer Roundup, but a second jury finding on Tuesday that the product caused cancer has narrowed the company's options, some legal experts said.
Categories: Health

Jazz Pharma's sleep disorder treatment gets FDA nod

Health News (Reuters) - 15 hours 37 min ago
The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.
Categories: Health

Congo Ebola outbreak spreads to city of Bunia

Health News (Reuters) - Wed, 03/20/2019 - 23:27
Health authorities in Democratic Republic of Congo have confirmed a case of Ebola in another city of close to 1 million people, the health ministry said on Wednesday.
Categories: Health

With ADHD, amphetamine has double the psychosis risk of methylphenidate

Health News (Reuters) - Wed, 03/20/2019 - 22:10
(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say.
Categories: Health

U.S. jury hears more evidence as second phase of Roundup cancer trial begins

Health News (Reuters) - Wed, 03/20/2019 - 21:52
A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease.
Categories: Health

FDA allows sale of certain blood pressure drugs amid shortage

Health News (Reuters) - Wed, 03/20/2019 - 21:01
The U.S. Food and Drug Administration on Wednesday said it will temporarily allow certain manufacturers to sell blood pressure medications containing specified levels of a probable cancer-causing impurity in order to maintain adequate supplies of the drug.
Categories: Health

Study finds key details about 'punch drunk syndrome' and Alzheimer's

Health News (Reuters) - Wed, 03/20/2019 - 19:07
Scientists studying damaged brains of boxers and other sports people have found key details about a head injury-linked disease called "punch drunk syndrome" that could help the development of new diagnostics and treatments for Alzheimer's.
Categories: Health

Zambia bans energy drink with male sex booster Viagra

Health News (Reuters) - Wed, 03/20/2019 - 18:43
Zambia banned an energy drink on Wednesday after it was shown to have been adulterated with the male sex booster Viagra, according to authorities in Ndola, the city of manufacture.
Categories: Health

Opioid prescriptions after plastic surgery tied to long-term use

Health News (Reuters) - Wed, 03/20/2019 - 18:39
(Reuters Health) - Opioids account for more than 90 percent of the painkillers used after plastic surgery, according to a U.S. study that questions how often these addictive narcotics are necessary to ease discomfort after operations.
Categories: Health

Novo Nordisk submits diabetes pill for U.S. approval

Health News (Reuters) - Wed, 03/20/2019 - 17:02
Novo Nordisk has submitted its oral semaglutide drug, a pill it hopes will transform the diabetes market, for approval in the United States.
Categories: Health

Bayer shares slide after latest Roundup cancer ruling

Health News (Reuters) - Wed, 03/20/2019 - 16:59
Shares in Germany's Bayer's fell more than 12 percent on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer.
Categories: Health

Sage gets U.S. approval for first postpartum depression therapy

Health News (Reuters) - Wed, 03/20/2019 - 15:36
The U.S. Food and Drug Administration on Tuesday approved Sage Therapeutics Inc's drug for postpartum depression, marking the first approval of a treatment specifically developed for the condition that affects a new mother's ability to care for herself or her baby.
Categories: Health

Living alone does not appear to worsen heart disease

Health News (Reuters) - Wed, 03/20/2019 - 15:33
(Reuters Health) - For people with well-controlled heart disease, living alone isn't linked with a higher risk of cardiovascular problems, a large study suggests.
Categories: Health

Piles of pigs: Swine fever outbreaks go unreported in rural China

Health News (Reuters) - Wed, 03/20/2019 - 10:22
When pigs on the Xinda Husbandry Co. Ltd breeding farm in northern China began dying in growing numbers in early January, it looked increasingly likely that the farm had been struck by the much feared African swine fever, an incurable disease that has spread rapidly across the country since last year.
Categories: Health

Second U.S. jury finds Bayer's Roundup caused cancer

Health News (Reuters) - Wed, 03/20/2019 - 08:39
A U.S. jury on Tuesday found Bayer AG's glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case.
Categories: Health

San Francisco officials look to ban sale of e-cigarettes

Health News (Reuters) - Wed, 03/20/2019 - 03:08
San Francisco officials on Tuesday proposed legislation that would ban the sale of e-cigarettes from companies such as Juul until a review by the U.S. Food and Drug Administration, as part of the city's efforts to tackle underage vaping.
Categories: Health

Daily cannabis and skunk users run higher psychosis risk

Health News (Reuters) - Wed, 03/20/2019 - 00:46
People who use cannabis every day run a significantly higher risk of developing the serious mental illness psychosis, especially if they use more potent forms of the drug, such as skunk, scientists said.
Categories: Health
Syndicate content

eXTReMe Tracker